U.S. market Closed. Opens in 16 hours 26 minutes

FREQ | Frequency Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
RevenueN/A14.07M36.98M28.95MN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/A
Gross ProfitN/A14.07M36.98M28.95MN/AN/A
Operating Expenses83.00M98.10M64.53M49.62M18.94M16.31M
Selling, General & Admin33.58M37.18M27.12M30.84M7.06M4.34M
Research & Development49.42M60.92M37.41M18.78M11.88M11.97M
Other Operating Expenses1.06M-266.00KN/A16.00MN/AN/A
Operating Income-83.00M-84.03M-27.55M-20.68M-18.94M-16.31M
Other Expenses / Income1.42M-640.00K1.07M1.93M-118.00K-3.93M
Before Tax Income-81.58M-84.67M-26.48M-18.75M-19.17M-20.24M
Income Tax Expenses-2.00K15.00K35.00K-2.74M-118.00KN/A
Net Income-81.58M-84.69M-26.51M-16.00M-19.17M-20.24M
Interest Expenses961.00K764.00KN/A1.78M106.00K174.00K
Basic Shares Outstanding35.08M34.35M32.25M8.65M12.06M18.12M
Diluted Shares Outstanding35.08M34.35M32.25M8.65M12.06M18.12M
EBITDA-80.62M-81.12M-27.63M-20.82M-18.29M-19.53M
EBITDA Margin0.00%-576.66%-74.71%-71.92%0.00%0.00%
EBIT-80.62M-83.91M-26.48M-16.96M-19.18M-20.06M
EBIT Margin0.00%-596.44%-71.59%-58.60%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙